glp 1 approved for pediatrics GLP-1 agonists in pediatric obesity: an integrative perspective on cell signaling, development, and metabolism GLP-1 medications for weight loss

If confirmed in prospective studies, GLP-1RAs could represent the first medical therapy demonstrated to reduce rupture risk in observational data, offering a novel treatment option for patients with unruptured aneurysms who are not ideal surgical candidates due to smaller aneurysm size, older age, high surgical risk, or patient preference

Soil amendments and fumigation for the management of Fusarium wilt of bunching spinach in Ontario, Canada

A pose-independent method for accurate and precise body composition from 3D optical scans

Particulate matter air pollution and cardiovascular disease: an update to the scientific statement from the american heart association

Anti-inflammatory and barrier-stabilising effects of myrrh, coffee charcoal and chamomile flower extract in a co-culture cell model of the intestinal mucosa